Advances in Nanocarriers for Anticancer Drugs Delivery
- PMID: 27048343
- DOI: 10.2174/0929867323666160405111152
Advances in Nanocarriers for Anticancer Drugs Delivery
Abstract
Cancer is the most dangerous disease to haunt the mankind in the world today. Generally, the overall cancer mortality rates are similar in both the sexes. The reasons for most of these deaths are inefficacy and failure of the current methods of treatments or the unavailability of treatment options. The researchers of the world are actively integrating nanotechnology of treating of various cancers. The development of smart nanocarriers is one of the most important innovations in this direction. The nanocarriers of the different materials are being developed to improve the efficacy of current treatments. The present article describes the role of nanotechnology in cancer treatment emphasizing cancer nanotherapy, nanocarriers for drug delivery, types and the mechanisms of the nanocarriers. Besides, the efforts are made to discuss the recent advances in the nanocarriers, current challenges and the future prospective.
Similar articles
-
Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.Curr Drug Targets. 2016;17(2):206-28. doi: 10.2174/1389450116666150722141607. Curr Drug Targets. 2016. PMID: 26201484 Review.
-
Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).Recent Pat Anticancer Drug Discov. 2014 Jan;9(1):99-128. doi: 10.2174/1574891x113089990038. Recent Pat Anticancer Drug Discov. 2014. PMID: 23578193 Review.
-
Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.Ther Deliv. 2017 Nov;8(11):967-985. doi: 10.4155/tde-2017-0075. Ther Deliv. 2017. PMID: 29061106 Review.
-
Advances in stimuli responsive nanobiomaterials for cancer therapy.J Biomed Nanotechnol. 2014 Mar;10(3):367-82. doi: 10.1166/jbn.2014.1778. J Biomed Nanotechnol. 2014. PMID: 24730233 Review.
-
Nanocarriers as an emerging platform for cancer therapy.Nat Nanotechnol. 2007 Dec;2(12):751-60. doi: 10.1038/nnano.2007.387. Nat Nanotechnol. 2007. PMID: 18654426 Review.
Cited by
-
Iron-Based Magnetic Nanosystems for Diagnostic Imaging and Drug Delivery: Towards Transformative Biomedical Applications.Pharmaceutics. 2022 Sep 30;14(10):2093. doi: 10.3390/pharmaceutics14102093. Pharmaceutics. 2022. PMID: 36297529 Free PMC article. Review.
-
Facile synthesis of indole heterocyclic compounds based micellar nano anti-cancer drugs.RSC Adv. 2018 Nov 13;8(66):37905-37914. doi: 10.1039/c8ra07060a. eCollection 2018 Nov 7. RSC Adv. 2018. PMID: 35558619 Free PMC article.
-
FLI-1-driven regulation of endothelial cells in human diseases.J Transl Med. 2024 Aug 6;22(1):740. doi: 10.1186/s12967-024-05546-4. J Transl Med. 2024. PMID: 39107790 Free PMC article. Review.
-
Dual-Functional Iron Oxide Nanoparticles Coated with Polyvinyl Alcohol/5-Fluorouracil/Zinc-Aluminium-Layered Double Hydroxide for a Simultaneous Drug and Target Delivery System.Polymers (Basel). 2021 Mar 10;13(6):855. doi: 10.3390/polym13060855. Polymers (Basel). 2021. PMID: 33802205 Free PMC article.
-
TCL1A-expressing B cells are critical for tertiary lymphoid structure formation and the prognosis of oral squamous cell carcinoma.J Transl Med. 2024 May 19;22(1):477. doi: 10.1186/s12967-024-05292-7. J Transl Med. 2024. PMID: 38764038 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources